Absence of First-order Transition and Tri-critical Point in the Dynamic Phase Diagram of a Spatially Extended Bistable System in an Oscillating Field

It has been well established that spatially extended, bistable systems that are driven by an oscillating field exhibit a nonequilibrium dynamic phase transition (DPT). The DPT occurs when the field frequency is on the order of the inverse of an intrinsic lifetime associated with the transitions between the two stable states in a static field of the same magnitude as the amplitude of the oscillating field. The DPT is continuous and belongs to the same universality class as the equilibrium phase transition of the Ising model in zero field [G. Korniss et al., Phys. Rev. E 63, 016120 (2001); H. Fujisaka et al., Phys. Rev. E 63, 036109 (2001)]. However, it has previously been claimed that the DPT becomes discontinuous at temperatures below a tricritical point [M. Acharyya, Phys. Rev. E 59, 218 (1999)]. This claim was based on observations in dynamic Monte Carlo simulations of a multipeaked probability density for the dynamic order parameter and negative values of the fourth-order cumulant ratio. Both phenomena can be characteristic of discontinuous phase transitions. Here we use classical nucleation theory for the decay of metastable phases, together with data from large-scale dynamic Monte Carlo simulations of a two-dimensional kinetic Ising ferromagnet, to show that these observations in this case are merely finite-size effects. For sufficiently small systems and low temperatures, the continuous DPT is replaced, not by a discontinuous phase transition, but by a crossover to stochastic resonance. In the infinite-system limit the stochastic-resonance regime vanishes, and the continuous DPT should persist for all nonzero temperatures

Efficacy and tolerability of trastuzumab emtansine in advanced human epidermal growth factor receptor 2–positive breast cancer

© 2018, Hong Kong Academy of Medicine Press. All rights reserved. Introduction: The management of human epidermal growth factor receptor 2 (HER2)–positive breast cancer has changed dramatically with the introduction and widespread use of HER2-targeted therapies. There is, however, relatively limited real-world information about the effectiveness and safety of trastuzumab emtansine (T-DM1) in Hong Kong Chinese patients. We assessed the efficacy and toxicity profiles among local patients with HER2-positive advanced breast cancer who had received T-DM1 therapy in the second-line setting and beyond. Methods: This retrospective study involved five local centres that provide service for over 80% of the breast cancer population in Hong Kong. The study period was from December 2013 to December 2015. Patients were included if they had recurrent or metastatic histologically confirmed HER2+ breast cancer who had progressed after at least one line of anti-HER2 therapy including trastuzumab. Patients were excluded if they received T-DM1 as first-line treatment for recurrent or metastatic HER2+ breast cancer. Patient charts including biochemical and haematological profiles were reviewed for background information, T-DM1 response, and toxicity data. Adverse events were documented during chemotherapy and 28 days after the last dose of medication. Results: Among 37 patients being included in this study, 28 (75.7%) had two or more lines of anti-HER2 agents and 26 (70.3%) had received two or more lines of palliative chemotherapy. Response assessment revealed that three (8.1%) patients had a complete response, eight (21.6%) a partial response, 11 (29.7%) a stable disease, and 12 (32.4%) a progressive disease; three patients could not be assessed. The median duration of response was 17.3 (95% confidence interval, 8.4-24.8) months. The clinical benefit rate (complete response + partial response + stable disease, ≥12 weeks) was 37.8% (95% confidence interval, 22.2%-53.5%). The median progression-free survival was 6.0 (95% confidence interval, 3.3-9.8) months and the median overall survival had not been reached by the data cut-off date. Grade 3 or 4 toxicities included thrombocytopaenia (13.5%), raised alanine transaminase (8.1%), anaemia (5.4%), and hypokalaemia (2.7%). No patient died as a result of toxicities. Conclusions: In patients with HER2-positive advanced breast cancer who have been heavily pretreated with anti-HER2 agents and cytotoxic chemotherapy, T-DM1 is well tolerated and provided a meaningful progression-free survival of 6 months and an overall survival that has not been reached. Further studies to identify appropriate patient subgroups are warranted.Link_to_subscribed_fulltex

Relativistic Mass Ejecta from Phase-transition-induced Collapse of Neutron Stars

We study the dynamical evolution of a phase-transition-induced collapse neutron star to a hybrid star, which consists of a mixture of hadronic matter and strange quark matter. The collapse is triggered by a sudden change of equation of state, which result in a large amplitude stellar oscillation. The evolution of the system is simulated by using a 3D Newtonian hydrodynamic code with a high resolution shock capture scheme. We find that both the temperature and the density at the neutrinosphere are oscillating with acoustic frequency. However, they are nearly 180$^{\circ}$ out of phase. Consequently, extremely intense, pulsating neutrino/antineutrino fluxes will be emitted periodically. Since the energy and density of neutrinos at the peaks of the pulsating fluxes are much higher than the non-oscillating case, the electron/positron pair creation rate can be enhanced dramatically. Some mass layers on the stellar surface can be ejected by absorbing energy of neutrinos and pairs. These mass ejecta can be further accelerated to relativistic speeds by absorbing electron/positron pairs, created by the neutrino and antineutrino annihilation outside the stellar surface. The possible connection between this process and the cosmological Gamma-ray Bursts is discussed.Comment: 40 pages, 11 figures, accepted for publication in JCA

Gravitational Coupling and Dynamical Reduction of The Cosmological Constant

We introduce a dynamical model to reduce a large cosmological constant to a sufficiently small value. The basic ingredient in this model is a distinction which has been made between the two unit systems used in cosmology and particle physics. We have used a conformal invariant gravitational model to define a particular conformal frame in terms of large scale properties of the universe. It is then argued that the contributions of mass scales in particle physics to the vacuum energy density should be considered in a different conformal frame. In this manner, a decaying mechanism is presented in which the conformal factor appears as a dynamical field and plays a key role to relax a large effective cosmological constant. Moreover, we argue that this model also provides a possible explanation for the coincidence problem.Comment: To appear in GR

Removal of cationic dye methyl violet 2B from water by cation exchange membranes

The removal of methyl violet 28, a cationic dye, from water using two kinds of strong-acid cation exchange membranes, ICE 450 supported (with sulfonic acid groups and ion exchange capacity of 9.6-31 mu eq/47 mm disc) and P81 (with phosphate groups and ion exchange capacity of 312 mu eq/47 mm disc), was investigated in this study. In the batch process, the adsorption isotherm results show that the P81 membrane exhibited a greater maximum adsorption capacity than the ICE 450 supported membrane. However, the latter exhibited stronger and faster dye adsorption behaviors. Different desorption solutions were tested in the batch desorption process and, for both membranes, the best desorption performance (similar to 100%) was achieved with an aqueous solution containing 1 M NaCl in 60% methanol. In the membrane chromatography process with one piece of 47 mm membrane at a flow rate of 1 or 8 mL/min, complete dye removal and recovery from a 20 mL feed with an initial dye concentration of 0.015 g/L could be achieved for both membranes. The performance of both membranes remained practically unaltered during three successive cycles of dye adsorption and desorption. Lastly, to mimic the effluent produced by a typical dyehouse, a synthetic dye wastewater made up of 0.03 g/L methyl violet 2B and 2 g/L Na(2)SO(4) at pH 3 and 100 degrees C was prepared and treated by both membranes in the membrane chromatography process. The extent of dye removal was decreased to 84-93% for the P81 membrane, which may be attributable to either salt ion competition or pH influence. By contrast, the ICE 450 supported membrane could attain nearly complete dye adsorption and desorption. (C) 2007 Elsevier B.V. All rights reserved

Removal of anionic reactive dyes from water using anion exchange membranes as adsorbers

Two commercial anion exchange membranes, strong basic (SB6407) and weak basic (DE81), were evaluated for the removal of anionic reactive dyes, Cibacron blue 3GA (three sulfonic acid groups per dye molecule) and Cibacron red 3BA (four sulfonic acid groups per dye molecule), from water in this study. The adsorption isotherm results show that the Langmuir maximum adsorption capacities of Cibacron blue 3GA (31.5 mg/cm(3) for SB6407 and 25.5 mg/cm(3) for DE81) were greater than those of Cibacron red 3BA (24.5 mg/cm(3) for SB6407 and 18.5 mg/cm(3) for DE81). For each reactive dye, the capacity for SB6407 was higher than DE81 based on the same membrane volume. However, consideration of the number of ion exchange sites interacting with a dye molecule indicates that the DE81 results are close to the theoretical values while the SB6407 membrane had some unused binding sites. In addition, Cibacron red 3BA demonstrated faster and stronger binding with both anion exchange membranes than Cibacron blue 3GA. Both dyes could bind with strong basic SB6407 more quickly and stronger. In the batch desorption process, different desorption solutions were tested and the mixtures of salt, acid, or base in methanol solution (e.g. 1N KSCN in 60% methanol or 1N HCl in 60% methanol) achieved better performance. Finally, in the flow process with one piece of anion exchange membrane (initial dye concentration of 0.05 g/L), SB6407 was found superior to DE81 in dye recovery and both membranes retained their original uptake capacities over three cycles of adsorption, washing, and desorption. (c) 2007 Elsevier Ltd. All rights reserved

Gallic Acid Induces Apoptosis via Caspase-3 and Mitochondrion-Dependent Pathways in Vitro and Suppresses Lung Xenograft Tumor Growth in Vivo

Several studies have shown that gallic acid (GA) induces apoptosis in different cancer cell lines, whereas the mechanism of action of GA-induced apoptosis at the molecular level in human non-small-cell lung cancer NCI-H460 cells is not well-known, Here, GA decreasing the percentage of viable NCI-H460 cells was investigated; GA-induced apoptosis involved G2/M phase arrest and intracellular Ca(2+) production, the loss of mitochondrial membrane potential (Delta Psi(m)), and caspase-3 activation, The efficacious induction of apoptosis and DNA damage was observed at 50-500 mu M for 24 and/or 48 h as examined by flow cytometry, DAPI staining, and Comet assay methods. Western blotting and flow cytometric analysis also demonstrated that GA increased protein levels of GADD153 and GRP78, activation of caspase-8, -9, and -3, loss of Alp. and cytochrome c, and AIF release from mitochondria. Moreover, apoptosome formation and activation of caspase cascade were associated with apoptotic cell death. GA increased Sax and Bad protein levels and decreased Bcl-2 and Bcl-xL levels. GA may also induce apoptosis through a caspase-independent AIF pathway. In nude mice bearing NCI-H460 xenograft tumors, GA inhibited tumor growth in vivo. The data suggest that GA induced apoptosis In NCI-H460 lung cancer cells via a caspase-3 and mitochondrion-dependent pathway and inhibited the in vivo tumor growth of NCI-H460 cells in xenograft models